BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Biotech Beach

  Binding Sites for LIN28 Protein Found in Thousands of Human Genes, University of California, San Diego (UCSD) Study

  September 5, 2012

   · 

  1 min read
• Biotech Beach

  University of Central Florida Team Reports Brain-Controlled Ambulation in Robotic Leg Test

  September 5, 2012

   · 

  1 min read
• Drug Development

  TG Therapeutics, Inc. Initiates a Phase I/II Clinical Trial of Its Novel Third-Generation Anti-CD20 Monoclonal Antibody, Ublituximab, in Patients With Relapsed or Refractory B-cell Non-Hodgkin’s Lymphoma

  September 5, 2012

   · 

  1 min read
• FDA

  Shire plc’s DERMAGRAFT® Approved in Canada for Treatment of Diabetic Foot Ulcers

  September 5, 2012

   · 

  5 min read
• Business

  Fedora Pharmaceuticals Inc. Appoints Thomas R. Parr, Ph.D., Chief Scientific Officer

  September 5, 2012

   · 

  1 min read
• FDA

  Surefire Medical, Inc.'s Infusion System for Embolization Procedures Receives CE Mark Approval

  September 5, 2012

   · 

  1 min read
• Business

  Teva Pharmaceutical Industries Limited Chair Should Fly Business Class: Shareholder

  September 5, 2012

   · 

  1 min read
• Deals

  Intercept Pharmaceuticals Files for $75 Million IPO

  September 5, 2012

   · 

  2 min read
• Roche Vows to Keep Up Drug Hunt; to Strengthen Pipeline With 72 New Molecular Entities

  September 5, 2012

   · 

  1 min read
• Policy

  Salix Pharmaceuticals, Ltd.'s Dragon’s Blood Drug for Diarrhea Delayed by FDA

  September 5, 2012

   · 

  5 min read